Trial Profile

A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cabotegravir (Primary)
Indications HIV infections
Focus Pharmacokinetics
Sponsors ViiV Healthcare

Most Recent Events

01 Jan 2019 Results assessing pharmacokinetics and safety of Cabotegravirin hepatic impairment patient and healthy voulnteers published in the Clinical Pharmacology in Drug Development
08 Oct 2017 Results presented at the IDWeek 2017
27 Sep 2016 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com